Experimental blood test detects early breast cancer and predicts recurrence

Researchers have developed a new liquid biopsy blood test that accurately detects early-stage breast cancer and predicts the risk of recurrence. The test analyzes epigenetic signatures to outperform traditional tissue biopsies.
Why it matters
This breakthrough could significantly improve cancer survival rates by enabling earlier diagnosis and more personalized treatment plans.
edited by Lisa Lock , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in